Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-26916

Xla wt + cdc42ep3 MO + eGFP + explant, Kho M et al. (2019)

Experiment + Assay: Xla wt + cdc42ep3 MO + eGFP + explant + NF17-22 (Other Detection Assay)
Background: Xla.J-strainNXR
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection cdc42ep3 MO1 cdc42ep3 (Xla)
 NF stage 2 (2-cell) blastomere
explant  
NF stage 17 presumptive axial mesoderm
DNA injection Tg(eGFP)
NF stage 17 presumptive axial mesoderm
Conditions:
Assay Type Assay Stages Antibody
Other Detection Assay NF stage 17 to NF stage 22  
Anatomical Phenotypes: abnormal presomitic mesoderm , abnormal somite morphology
Article: XB-ART-55982, PubMed